1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Tiziano Frateschi
Tiziano Frateschi
Articles (1435)  | Author's Website |

5 Health Care Stocks in Gurus' Portfolios

Amgen, Innoviva among stocks investors are buying

January 08, 2018 | About:

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Twenty-two gurus are invested in Amgen Inc. (NASDAQ:AMGN).

The biotechnology company has a market cap of $131.14 billion. Its revenue has grown 10.50% annually over the past 10 years.

The stock is trading with a price-earnings (P/E) ratio of 16.31. The current stock price of $180.65 is 5.47% below its 52-week high and 20.13% above its 52-week low. Over the past decade, it has returned a gain of 279%.

The company’s largest shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with 3.07% of outstanding shares, followed by Jim Simons (Trades, Portfolio) with 0.54%, David Carlson (Trades, Portfolio) with 0.06% and Pioneer Investments (Trades, Portfolio) with 0.04%.

Seven gurus have positions in Innoviva Inc. (NASDAQ:INVA).

The biopharmaceutical company has a market cap of $1.53 billion. Its revenue has declined 3.50% annually over the past decade.

The current stock price of $14.19 is 4.57% below its 52-week high and 37.77% above its 52-week low. Over the past 10 years, it has returned a loss of 14%.

First Eagle Investment (Trades, Portfolio) is the company's largest guru shareholder with 3.63% of outstanding shares, followed by Simons with 2% and Steven Cohen (Trades, Portfolio) with 1.78%.

Four gurus are invested in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA).

The drugmaker has a market cap of $685.13 million. The current stock price of $15.25 is 19.69% below its 52-week high and 28.15% above its 52-week low. Over the past 10 years, it has returned a gain of 168%.

With 2.71% of outstanding shares, Simons is the company's largest guru shareholder, followed by Joel Greenblatt (Trades, Portfolio) with 0.32%.

Six gurus have positions in Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY).

The biopharmaceutical company has a market cap of $12.67 billion. Its revenue has declined 10.90% annually over the past 10 years.

The current stock price of $127.73 is 13.48% below its 52-week high and 255% above its 52-week low. Over the past decade, it has returned a gain of 307%.

Dodge & Cox is the company's largest guru shareholder with 9.22% of outstanding shares, followed by the Vanguard Health Care Fund (Trades, Portfolio) with 8.01% and John Griffin (Trades, Portfolio) with 1.54%.

Six gurus are invested in Xencor Inc. (NASDAQ:XNCR).

The biotechnology company has a market cap of $1.07 billion.

The current stock price of $22.83 is 20.29% below its 52-week high and 23.07% above its 52-week low. Over the past decade, it has returned a gain of 174%.

The company’s largest guru shareholder is PRIMECAP Management with 19.56% of outstanding shares, followed by Simons with 0.32%, Greenblatt with 0.31% and Cohen with 0.16%.

Disclosure: I do not own any stocks mentioned in this article.

About the author:

Tiziano Frateschi
You can read about me on this blog: www.theextraincome.info

It gives suggestions on position trading.

Visit Tiziano Frateschi's Website


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Tiziano Frateschi


User Generated Screeners


pughplNet-Net_Low_PE
pughplNet-Net_W_Dividends
cspunarTradeables1
cspunarIndustry/Sector1
pbarker46Banks
DANGORDON4-8-18 PORTFOLIO
danccchanIndustry Research
danccchanValue Investing
JoeKafkaROC35
comundongoBen Graham NNWC Screen Updated
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK